keyboard_arrow_up

Worldwide Report: Anxiety Disorders Market Growth and Forecast 2019

Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers ‘fight or flight’ response. Anxiety without an identifiable cause, anxiety which persists even after the stressful condition is over, and anxiety which is out of proportion of the stressful condition indicates abnormal anxiety. However, severe and persistent anxiety can interfere with everyday activities and might lead to other psychic problems. Anxiety disorder is a mental health disorder characterized by the presence of anxiety. These disorders might occur simultaneously with other disorders such as depression, or along with drug abuse.

Analysts forecast the Global Anxiety Disorders market to grow at a CAGR of 4.02 percent over the period 2014-2019.

This report covers the present scenario and the growth prospects of the Global Anxiety Disorders market for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of drugs approved for the treatment of the following anxiety disorders:

  • GAD
  • Panic Disorder
  • OCD
  • PTSD
  • Social Anxiety Disorder
  • Special Phobias
  • BDD

The report presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Anxiety Disorders market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

Global Anxiety Disorders Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Anxiety Disorders market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Eli Lilly and Company
  • GlaxoSmithKline
  • Pfizer

Other Prominent Vendors

  • Abbott Laboratories
  • Actavis
  • Baxter International
  • F. Hoffmann-La Roche
  • Noven Pharmaceuticals
  • Recordati Rare Diseases
  • Shionogi
  • Sumitomo Dainippon Pharma

Market Driver

  • Increase in Patient Population

Market Challenge

  • Poor Diagnoses Rates

Market Trend

  • Increased Focus on Emerging Markets

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

 

Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=29736 .

(Prices start at US $2500 for a single user PDF)